GSK Dodges Avandia Side-Effect Disclosure Class Action
A Pennsylvania federal judge has ruled that the lead plaintiff in a proposed class action rolled into multidistrict litigation covering claims that GlaxoSmithKline LLC concealed dangerous side effects of its diabetes...To view the full article, register now.
Already a subscriber? Click here to view full article